Epizyme Depreciation & Amortization 2011-2025 | EPZM

Annual Depreciation & Amortization Epizyme

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
5.25 M	3.98 M	840 K	1.05 M	1.64 M	1.59 M	1.42 M	742 K	703 K	847 K	479 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
5.25 M	479 K	1.69 M

Quarterly Depreciation & Amortization Epizyme

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	2.58 M	1.3 M	-	1 M	2.6 M	1.28 M	-	2.67 M	1.36 M	512 K	-	626 K	416 K	207 K	-	804 K	582 K	361 K	-	1.23 M	824 K	411 K	-	1.19 M	791 K	389 K	-	1.06 M	653 K	260 K	-	548 K	362 K	169 K	-	534 K	363 K	179 K	-	440 K	292 K	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.67 M	169 K	838 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Amphastar Pharmaceuticals AMPH	28.2 M	$ 25.37	-2.07 %	$ 1.23 B	USA
Arbutus Biopharma Corporation ABUS	1.4 M	$ 4.75	1.61 %	$ 788 M	Canada
Aclaris Therapeutics ACRS	807 K	$ 3.28	-2.53 %	$ 254 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	9.45 M	-	-15.15 %	$ 60.3 M	Britain
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Aptorum Group Limited APM	1.13 M	$ 1.31	-1.88 %	$ 7.14 M	China
Anika Therapeutics ANIK	6.43 M	$ 9.56	0.75 %	$ 140 M	USA
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.35	3.07 %	$ 14.8 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Baudax Bio BXRX	165 K	-	0.59 %	$ 63 K	USA
ChromaDex Corporation CDXC	663 K	-	-0.88 %	$ 598 M	USA
Axon Enterprise AXON	48.4 M	$ 568.3	-2.19 %	$ 43 B	USA
Caladrius Biosciences CLBS	174 K	-	-16.75 %	$ 25.8 M	USA
Clovis Oncology CLVS	8.5 M	-	-7.23 %	$ 13 M	USA
Biogen BIIB	673 M	$ 174.78	1.32 %	$ 25.4 B	USA
BioVie BIVI	229 K	$ 1.46	-3.31 %	$ 2.16 M	USA
Cortexyme CRTX	322 K	-	-1.05 %	$ 67.1 M	USA
Benitec Biopharma BNTC	66 K	$ 12.34	-4.78 %	$ 508 M	USA
Deciphera Pharmaceuticals DCPH	2.1 M	-	-	$ 2.18 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	24.9 M	$ 11.5	0.52 %	$ 744 M	USA
Eloxx Pharmaceuticals ELOX	77 K	-	-5.68 %	$ 8.28 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 0.28	-2.28 %	$ 609 M	Israel
Catalyst Biosciences CBIO	1.07 M	$ 14.62	-4.54 %	$ 962 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Cerus Corporation CERS	1.86 M	$ 2.17	0.7 %	$ 401 M	USA
Enochian Biosciences ENOB	129 K	-	-	$ 40.5 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA